Repository logo
 

MitoQ Prevents Human Breast Cancer Recurrence and Lung Metastasis in Mice.

Published version
Peer-reviewed

Change log

Authors

Krzystyniak, Joanna 
Rodriguez, Amanda Canas 
Payen, Valéry L 

Abstract

In oncology, the occurrence of distant metastases often marks the transition from curative to palliative care. Such outcome is highly predictable for breast cancer patients, even if tumors are detected early, and there is no specific treatment to prevent metastasis. Previous observations indicated that cancer cell mitochondria are bioenergetic sensors of the tumor microenvironment that produce superoxide to promote evasion. Here, we tested whether mitochondria-targeted antioxidant MitoQ is capable to prevent metastasis in the MDA-MB-231 model of triple-negative human breast cancer in mice and in the MMTV-PyMT model of spontaneously metastatic mouse breast cancer. At clinically relevant doses, we report that MitoQ not only prevented metastatic take and dissemination, but also local recurrence after surgery. We further provide in vitro evidence that MitoQ does not interfere with conventional chemotherapies used to treat breast cancer patients. Since MitoQ already successfully passed Phase I safety clinical trials, our preclinical data collectively provide a strong incentive to test this drug for the prevention of cancer dissemination and relapse in clinical trials with breast cancer patients.

Description

Keywords

MitoQ, breast cancer, cancer relapse, metastasis, metastasis prevention, mitochondria, mitochondria-targeted antioxidant, mitochondrial superoxide, translational research

Journal Title

Cancers (Basel)

Conference Name

Journal ISSN

2072-6694
2072-6694

Volume Title

14

Publisher

MDPI AG
Sponsorship
European Commission Horizon 2020 (H2020) Marie Sk?odowska-Curie actions (722605)